AtriCure Gross Profit vs Reconciled Depreciation Analysis
ATRC Stock | USD 23.37 0.20 0.86% |
AtriCure financial indicator trend analysis is way more than just evaluating AtriCure prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether AtriCure is a good investment. Please check the relationship between AtriCure Gross Profit and its Reconciled Depreciation accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AtriCure. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.
Gross Profit vs Reconciled Depreciation
Gross Profit vs Reconciled Depreciation Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of AtriCure Gross Profit account and Reconciled Depreciation. At this time, the significance of the direction appears to have very strong relationship.
The correlation between AtriCure's Gross Profit and Reconciled Depreciation is 0.8. Overlapping area represents the amount of variation of Gross Profit that can explain the historical movement of Reconciled Depreciation in the same time period over historical financial statements of AtriCure, assuming nothing else is changed. The correlation between historical values of AtriCure's Gross Profit and Reconciled Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Gross Profit of AtriCure are associated (or correlated) with its Reconciled Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Reconciled Depreciation has no effect on the direction of Gross Profit i.e., AtriCure's Gross Profit and Reconciled Depreciation go up and down completely randomly.
Correlation Coefficient | 0.8 |
Relationship Direction | Positive |
Relationship Strength | Strong |
Gross Profit
Gross profit is a required income statement account that reflects total revenue of AtriCure minus its cost of goods sold. It is profit before AtriCure operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Reconciled Depreciation
Most indicators from AtriCure's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into AtriCure current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AtriCure. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.At present, AtriCure's Tax Provision is projected to increase significantly based on the last few years of reporting. The current year's Sales General And Administrative To Revenue is expected to grow to 0.78, whereas Enterprise Value Over EBITDA is projected to grow to (95.86).
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 205.9M | 245.9M | 297.4M | 312.3M | Total Revenue | 274.3M | 330.4M | 399.2M | 419.2M |
AtriCure fundamental ratios Correlations
Click cells to compare fundamentals
AtriCure Account Relationship Matchups
High Positive Relationship
High Negative Relationship
AtriCure fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 557.9M | 714.5M | 615.3M | 585.4M | 613.9M | 644.6M | |
Total Stockholder Equity | 247.3M | 412.4M | 483.8M | 456.8M | 466.2M | 489.5M | |
Retained Earnings | (282.2M) | (330.4M) | (280.2M) | (326.6M) | (357.1M) | (339.2M) | |
Other Assets | 705K | 16.5M | 955K | 2.0M | 1.0 | 0.95 | |
Common Stock Shares Outstanding | 37.6M | 42.1M | 46.0M | 45.7M | 46.3M | 24.2M | |
Liabilities And Stockholders Equity | 557.9M | 714.5M | 615.3M | 585.4M | 613.9M | 644.6M | |
Other Stockholder Equity | 529.7M | 742.4M | 764.8M | 787.4M | 824.2M | 865.4M | |
Total Liab | 310.5M | 302.1M | 131.6M | 128.7M | 147.8M | 80.4M | |
Other Current Liab | 32.8M | 28.0M | 36.1M | 33.0M | 44.7M | 46.9M | |
Total Current Liabilities | 49.9M | 49.1M | 56.4M | 58.4M | 74.6M | 78.3M | |
Accounts Payable | 14.9M | 12.7M | 18.6M | 19.9M | 27.4M | 28.7M | |
Cash | 28.5M | 41.9M | 43.7M | 58.1M | 84.3M | 88.5M | |
Inventory | 29.4M | 35.0M | 39.0M | 45.9M | 67.9M | 71.3M | |
Other Current Assets | 3.9M | 4.3M | 5.0M | 5.5M | 8.6M | 9.0M | |
Common Stock | 40K | 45K | 46K | 47K | 48K | 28.1K | |
Property Plant Equipment | 32.6M | 28.3M | 36.2M | 42.6M | 49.0M | 51.5M | |
Property Plant And Equipment Net | 36.7M | 30.2M | 36.2M | 42.6M | 46.8M | 49.1M | |
Net Debt | 47.9M | 32.1M | 32.0M | 11.0M | (9.8M) | (9.3M) | |
Non Current Assets Total | 414.7M | 407.8M | 419.2M | 370.2M | 347.7M | 365.1M | |
Non Currrent Assets Other | 705K | 440K | 955K | 2.0M | 2.2M | 2.3M | |
Cash And Short Term Investments | 81.8M | 244.2M | 119.1M | 121.1M | 137.3M | 144.1M | |
Net Receivables | 28.0M | 23.1M | 33.0M | 42.7M | 52.5M | 55.1M | |
Common Stock Total Equity | 40K | 45K | 46K | 47K | 54.1K | 28.2K | |
Non Current Liabilities Total | 260.6M | 253.0M | 75.1M | 70.3M | 73.2M | 60.0M | |
Property Plant And Equipment Gross | 36.7M | 30.2M | 36.2M | 42.6M | 99.2M | 104.1M | |
Total Current Assets | 143.2M | 306.7M | 196.1M | 215.2M | 266.2M | 279.6M | |
Accumulated Other Comprehensive Income | (158K) | 312K | (948K) | (4.1M) | (993K) | (943.4K) | |
Short Long Term Debt Total | 76.4M | 74.0M | 75.6M | 69.1M | 74.5M | 78.2M | |
Long Term Debt | 59.6M | 53.4M | 59.7M | 56.8M | 60.6M | 63.6M | |
Short Term Investments | 53.3M | 202.3M | 75.4M | 63.0M | 53.0M | 40.8M | |
Short Term Debt | 2.2M | 8.4M | 1.8M | 5.5M | 2.5M | 2.5M | |
Intangible Assets | 129.9M | 128.2M | 43.0M | 39.3M | 64.0M | 36.9M | |
Other Liab | 186.4M | 187.4M | 1.2M | 1.2M | 1.4M | 1.3M | |
Net Tangible Assets | (117.3M) | 49.4M | 206.0M | 182.6M | 210.0M | 220.5M | |
Retained Earnings Total Equity | (282.2M) | (330.4M) | (280.2M) | (326.6M) | (294.0M) | (308.7M) | |
Long Term Debt Total | 59.6M | 53.4M | 59.7M | 56.8M | 65.4M | 34.9M | |
Capital Surpluse | 529.7M | 742.4M | 764.8M | 787.4M | 905.5M | 470.9M | |
Non Current Liabilities Other | 201.0M | 199.6M | 15.4M | 13.5M | 1.2M | 1.2M |
Pair Trading with AtriCure
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AtriCure position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AtriCure will appreciate offsetting losses from the drop in the long position's value.Moving together with AtriCure Stock
0.62 | AHG | Akso Health Group | PairCorr |
Moving against AtriCure Stock
0.77 | GCTK | GlucoTrack | PairCorr |
0.75 | SNDA | Sonida Senior Living | PairCorr |
0.67 | TNDM | Tandem Diabetes Care Buyout Trend | PairCorr |
0.66 | JYNT | Joint Corp Financial Report 2nd of May 2024 | PairCorr |
0.47 | TLIS | Talis Biomedical Corp | PairCorr |
The ability to find closely correlated positions to AtriCure could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AtriCure when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AtriCure - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AtriCure to buy it.
The correlation of AtriCure is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AtriCure moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AtriCure moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AtriCure can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AtriCure. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Complementary Tools for AtriCure Stock analysis
When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
CEOs Directory Screen CEOs from public companies around the world |
Is AtriCure's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.66) | Revenue Per Share 8.621 | Quarterly Revenue Growth 0.21 | Return On Assets (0.03) | Return On Equity (0.07) |
The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.